Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

Coronary drug-eluting stent medical device reports that FDA received

FDA product code
NIQ
Device class
Class 3
Panel
Unknown

What a report is

A report is not proof that the device was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Device Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

Although MDRs are a valuable source of information, this passive surveillance system has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data. In addition, the incidence or prevalence of an event cannot be determined from this reporting system alone due to potential under-reporting of events and lack of information about frequency of device use.

Source: openFDA, Device Adverse Event Overview. The site read the page on .

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

Product code NIQ is the FDA classification for Coronary drug-eluting stent. The panel is Unknown. The device class is 3.

From May 2003 to September 2026, FDA received 129,027 medical device reports that have this product code.

FDA received 2,553 reports in the 12 months to September 2026 and 2,650 in the 12 months before. FDA releases MAUDE data every month. Reports can arrive months after an event, so the newest months grow in later releases.

Of the 3,444,740 device reports that FDA received in the 12 months to September 2026, 2,553 (0.1%) have this product code. Manufacturer reports were 98.7% of the reports that have this product code and 94.9% of all device reports.

The number of people who use the product is not in the data. A count is not a rate.

Product code

FDA gives each type of device a product code of three letters. A report has the code of its device, so a code has the reports of each brand of one device type.

Device class

Class I, II or III is the regulatory class of FDA for the device type. It is not a rating of a product.

Data version

openFDA MAUDE release of 23 Oct 2026. Reports received through 30 Sep 2026.

Brand names of this type

Brand names with product code NIQ that have a page, in order of name
Brand name, as written on reportsReportsReports, 12 months to September 2026
Cordis1940
Cypher Sirolimus-Eluting Coronary Stent15,0510
Endeavor Resolute Rx1,4790
Endeavor Resolute Rx Coronary Stent System2820
Endeavor Rx4560
Endeavor Rx Coronary Stent System5600
Endeavor Rx Drug-Eluting Coronary Stent System1540
Endeavor Sprint Rx2,4490
Endeavor Sprint Rx Coronary Stent System1,8210
Ion Paclitaxel-Eluting Platinum Chromium Coronary Stent System5590
Onyx Frontier1,056238
Onyx TruCor228132
Promus Element4,7700
Promus Element Everolimus-Eluting Coronary Stent System9590
Promus Element Long8900
Promus Element Plus5,2380
Promus Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System5300
Promus ELITE97147
Promus Everolimus Eluting Coronary Stent System2,7340
Promus PREMIER6,164106
Promus Premier Select91018
Resolute Integrity Rx4,72066
Resolute Onyx Rx5,82378
Synergy14,27177
Synergy Megatron42069
Synergy Xd2,829360
Taxus Element5570
Taxus Express2310
Taxus Express2 Drug-Eluting Coronary Stent2130
Taxus Express2 Paclitaxel-Eluting Coronary St2290
Taxus Express2 Paclitaxel-Eluting Coronary Stent1,5690
Taxus Express2 Paclitaxel-Eluting Coronary Stent System10,2560
Taxus Libert1,4510
Taxus Libert Atom1510
Taxus Libert Long2010
Taxus Liberte Paclitaxel-Eluting Coronary Stent3840
Taxus Liberte Paclitaxel-Eluting Coronary Stent System4,5430
Taxus R Libert R3590
Taxus Tm Libert Tm1550
Xience Alpine32599
Xience Alpine Everolimus Eluting Coronary Stent System2,6810
XIENCE Everolimus Eluting Coronary Stent System29732
Xience Prime22122
XIENCE PRIME Everolimus Eluting Coronary Stent System2,40210
Xience Prime Ll Everolimus Eluting Coronary Stent System1,4180
Xience Prime Sv Everolimus Eluting Coronary Stent System3080
Xience Pro Everolimus Eluting Rx Coronary Stent System3871
Xience Prox Everolimus Eluting Rx Coronary Stent System3440
XIENCE Sierra893139
XIENCE Sierra Everolimus Eluting Coronary Stent System1,3584
XIENCE Skypoint532264
Xience Skypoint Drug Eluting Coronary Stent Delivery System1,0630
Xience V Everolimus Eluting Coronary Stent System6,9909
XIENCE Xpedition663117
XIENCE Xpedition 48 Everolimus Eluting Coronary Stent System8584
Xience Xpedition Everolimus Eluting Coronary Stent System4,1990

The rows are in order of name. One product can have more than one spelling, and each spelling is a row.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Manufacturers named

The table has the 24 manufacturers with 5 or more reports that have this product code. The rows are in order of name. A manufacturer with fewer reports is not in the table.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Manufacturers that the reports with product code NIQ name, in order of name
Manufacturer, as written on reportsReports
Abbott19
Abbott Vascular8,376
Abbott Vascular-Cardiac Therapies2,977
Av-Temecula-Ct17,023
Biotronik488
Biotronik Buelach Switzerland2,245
Boston Scientific28,799
Boston Scientific - Galway23,638
Boston Scientific - Maple Grove5,353
Boston Scientific Ireland828
Cordis704
Cordis Cashel32
Cordis De Mexico8,025
Cordis Europa1,216
Cordis Miami6
Cordis Pr6,009
Medtronic16
Medtronic Cardiovascular110
Medtronic Cardiovascular Galway2,233
Medtronic Cardiovascular Santa Rosa24
Medtronic Ireland17,569
Medtronic Mexico6
Medtronic Perfusion Systems9
Medtronic Vascular54

Manufacturers, importers and device user facilities are mandatory reporters. The guide on what affects a count gives FDA's words.

Reports by month

Reports with product code NIQ, by month, five years to September 2026
025050020222023202420252026

FDA releases MAUDE data every month. Reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type in the reports with product code NIQ
Event typeReportsShareShare as a bar
Death11,2508.7%
Injury62,29048.3%
Malfunction55,19642.8%
Other1070.1%
Not given1840.1%
Source of the reports with product code NIQ
Report sourceReportsShareShare as a bar
Manufacturer report127,41298.7%
Voluntary report8920.7%
User facility report00%
Distributor report16under 0.1%
Not given7070.5%

The event type is the classification that the reporter gave. FDA does not verify it.

Device problems coded

Device problem codes in the reports with product code NIQ
Device problem (FDA code)ReportsShare
Failure to advance20,36615.8%
Occlusion within devicethe device blocked14,83111.5%
Material deformation13,82010.7%
Device remains implanted12,1999.5%
Device dislodged or dislocated10,9738.5%
Bent9,0867%
Difficult to removethe device was hard to remove7,7976%
Device damaged prior to usethe device was damaged before use4,7203.7%
Breakthe device broke3,9953.1%
Improper or incorrect procedure or method3,3592.6%
Detachment of device component2,4231.9%
Dislodged2,1911.7%
Replace2,1551.7%
Fracturea broken bone2,0351.6%
Device damaged by another device1,7741.4%
Difficult to advance1,7491.4%
Inflation problem1,6441.3%
Material rupture1,3331%
Kinkedthe tube or line kinked1,2871%
Activation, positioning or separation problem1,1530.9%

Official pages

The site checked these addresses on . The links open in a new tab.

Cite this page

Reported Reactions. Coronary drug-eluting stent (product code NIQ): medical device reports that FDA received. https://reportedreactions.com/device-type/niq/ Source: U.S. Food and Drug Administration, openFDA Device Adverse Event (MAUDE) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. Brand names, generic names and manufacturer names are as written on the reports. The names of the product codes come from the device classification of FDA.

The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What is product code NIQ?

It is the FDA classification code for Coronary drug-eluting stent, class 3, in the Unknown panel. Each device report has the product code of the device.

What event types do the reports record?

Death (11,250), injury (62,290), malfunction (55,196) and other (107). The event type is the classification that the reporter gave. FDA does not verify it.

Can the table of brand names rank the devices?

No. FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Brands also differ in the number of devices in use and in their time on the market.